Kala Bio (KALA) Interest & Investment Income (2016 - 2026)
Kala Bio (KALA) recorded Interest & Investment Income of $140,000 in Q2 2026, down 65.6% from $407,000 a year earlier but up 89.2% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Interest & Investment Income (2016 - 2026) Analysis & Trends
On a TTM basis, Kala Bio's Interest & Investment Income came in at $484,000 as of Jun 30, 2026, down 74.8% year-over-year; for FY2025, it came in at $1.14 million, down 44.6% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $2.06 million in FY2024 (-24.2%), $2.71 million in FY2023 (+308.3%), $664,000 in FY2022 (+538.5%) and $104,000 in FY2021 (-78.9%).
- Quarterly Interest & Investment Income has ranged from $8,000 in Q1 2022 to $718,000 in Q2 2023 over the past five years.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 955.9% in Q2 2023, against a decline of 84.0% in Q1 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kala Bio | 5.81 Mn | 5.81 Mn | - | 140,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Sep 30, 2025 | 270,000.00 |
| Jun 30, 2025 | 407,000.00 |
| Mar 31, 2025 | 463,000.00 |
| Dec 31, 2024 | 478,000.00 |
| Sep 30, 2024 | 570,000.00 |
| Jun 30, 2024 | 504,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Dec 31, 2023 | 610,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 718,000.00 |
| Mar 31, 2023 | 675,000.00 |
| Dec 31, 2022 | 354,000.00 |
| Sep 30, 2022 | 234,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 33,000.00 |
API Access
Kala Bio Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();